Methodology
Coverage status is explicit, and workflow readiness is earned rather than implied.
Histometrics separates tracked symbols into live, demo, and seeded coverage states. Public pages surface that status directly so users can see what is already validated in the database and what still depends on staged or sample coverage.
Coverage states
Live means a symbol has validated database-backed coverage powering the app right now, whether that data came from a primary provider or a validated website-seed backfill. Demo means the page and workflow are present, but one or more datasets still rely on seeded sample coverage. Seeded means the symbol is in the registry with a reserved ticker page or partial backfill while validation catches up.
This distinction is deliberate. Histometrics does not collapse “tracked” and “fully live” into the same label when the underlying data state is different.
Workflow-ready definition
Workflow-ready means a symbol can move through screen, ticker review, backtest, and memo generation on validated database-backed data without falling back to demo coverage. The public registry also shows blockers when a symbol is not yet ready for the full workflow.
In practice, workflow readiness depends on the datasets that power each surface: profile data, price history, income snapshots for income assets, distribution history, and, where needed, portfolio-composition context. Website-seed validation can draw that context from provider feeds, reviewed public fund pages, and structured SEC filing inputs such as Form N-PORT without changing the public status labels.
Timestamps and review context
Ticker pages and coverage rows expose visible as-of dates wherever possible. The coverage registry also shows its latest generated date so users can distinguish current tracked scope from future backlog.
Public pages are meant to reduce ambiguity, not hide it. If coverage is pending or a workflow is blocked by missing live data, the product is expected to say so directly.
Known limitations
Histometrics relies on configured data providers, database availability, and scheduled ingestion readiness. A ticker being present in the registry does not guarantee every dataset is live at the same time.
Advisor judgment still sits above the workflow. The product prepares research context and deliverable structure, but it does not eliminate the need for review before any recommendation is shared with a client.